Welcome to LookChem.com Sign In|Join Free
  • or
5-isobutyl-1-phenyl-1H-pyrazole-3-carboxylic acid is a complex organic compound with the molecular formula C14H15N2O2. It is a derivative of pyrazole, a heterocyclic compound with a five-membered ring containing three nitrogen atoms. This specific compound features an isobutyl group at the 5-position, a phenyl group at the 1-position, and a carboxylic acid group at the 3-position. It is known for its potential applications in pharmaceuticals and agrochemicals, particularly as a building block for the synthesis of various biologically active molecules. The compound's structure and properties make it a valuable intermediate in the development of new drugs and pesticides, highlighting its importance in the field of chemical research and development.

3191-85-3

Post Buying Request

3191-85-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3191-85-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 3191-85-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,1,9 and 1 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 3191-85:
(6*3)+(5*1)+(4*9)+(3*1)+(2*8)+(1*5)=83
83 % 10 = 3
So 3191-85-3 is a valid CAS Registry Number.

3191-85-3Relevant academic research and scientific papers

Novel pyrrolidine or piperidine derivatives having activity for T-type calcium channel

-

, (2020/04/23)

A pyrrolidine or piperidine compound having activity for T - type calcium channel, wherein the pyrrolidine or piperidine compound of Formula 1 according to the present invention has an excellent antagonistic activity to, T-type calcium channel, and can be used as a preventive or therapeutic agent, for pain diseases, or cancer related to cancer, or cancer such as, epilepsy and,hepatic pain, angina. (by machine translation)

Synthesis and biological evaluation of pyrrolidine-based T-type calcium channel inhibitors for the treatment of neuropathic pain

Yang, Hak Kyun,Son, Woo Seung,Lim, Keon Seung,Kim, Gun Hee,Lim, Eun Jeong,Gadhe, Changdev G.,Lee, Jae Yeol,Jeong, Kyu-Sung,Lim, Sang Min,Pae, Ae Nim

, p. 1460 - 1471 (2018/09/26)

The treatment of neuropathic pain is one of the urgent unmet medical needs and T-type calcium channels are promising therapeutic targets for neuropathic pain. Several potent T-type channel inhibitors showed promising in vivo efficacy in neuropathic pain a

Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers

Woo, Hyun Min,Lee, Yun Suk,Roh, Eun Joo,Seo, Seon Hee,Song, Chi Man,Chung, Hye Jin,Pae, Ae Nim,Shin, Kye Jung

, p. 5910 - 5915 (2011/10/09)

To obtain selective and potent inhibitor for T-type calcium channel by ligand based drug design, 4-piperidinecarboxylate and 4-piperidinecyanide derivatives were prepared and evaluated for in vitro and in vivo activity against α1G calcium channel. Among them, several compounds showed good T-type calcium channel inhibitory activity and minimal off-target activity over hERG channel (% inhibition at 10 μM = 61.85-71.99, hERG channel IC50 = 1.57 ± 0.14-4.98 ± 0.36 μM). Selected compound 31a was evaluated on SNL model of neuropathic pain and showed inhibitory effect on mechanical allodynia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3191-85-3